Exclusive Webinar :Gain complete knowledge about how you can invest in global markets during an insightful webinar on April 16 at 11 am. Register Now!
you are here: HomeNewsIndia

Kerala reports 4,106 new COVID-19 cases, 17 deaths

According to the release, 2,28,416 people are under observation out of which 8,006 are in isolation wards of various hospitals.

February 24, 2021 / 08:13 PM IST
Source: Reuters

Source: Reuters

Kerala logged 4,106 new cases of COVID-19 and 17 deaths on Wednesday, taking the caseload to 10,45,358 and toll to 4,136.

State Health Minister K K Shailaja said the state tested 70,568 samples in the last 24 hours and the test positivity rate was 5.82 per cent. She said 5,885 people recuperated from the disease, taking the total recoveries in the state to 9,87,720.

There are now 52,869 people under treatment in the state, the minister said in a release.

According to the release, 2,28,416 people are under observation out of which 8,006 are in isolation wards of various hospitals.

The state has tested 1,12,08,411 samples so far.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

She said out of the total number of people testing positive for the virus today, 107 had reached the state from outside while 3,174 contracted the disease through their contact.

Three people, who returned from the UK, tested positive in the last 24 hours, taking the total number of virus-affected UK returnees to 91.

"The sources of infection of 262 are yet to be traced while 23 health workers are also among the infected," the minister said.

Among the districts, Pathanamthittareported the highest number of cases--469, followed by Kozhikode with 465 and Enakulam 446.

No new hotspot was added today and five regions were removed from the list, taking its total number to 369.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Feb 24, 2021 08:12 pm

stay updated

Get Daily News on your Browser
Sections